DB06118ExperimentalProtein Based Therapies
EP-1043 is an epitope-based recombinant protein vaccine designed to induce HIV-1 specific helper T-lymphocyte (HTL) responses. The vaccine consists of a string of 18 HIV-derived major histocompatibility complex (MHC) Class... The epitopes included in the vaccine were selected using Epitope Identification System (EIS) and each of them is predicted to be recognized in the majority of the prospective patient population.
- Mechanism
- Curator reviewed
EP-1043 is an epitope-based recombinant protein vaccine designed to induce HIV-1 specific helper T-lymphocyte (HTL) responses.
- Primary indication
- Investigated for use/treatment in HIV prevention.Curator reviewed
- Code names
- EP-1043
Which companies are running trials of EP-1043, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account